Home > Healthcare > Medical Devices > Diagnostic Devices > Breast Biopsy Devices Market

Breast Biopsy Devices Market Trends

Report ID: GMI7441
Published Date: Nov 2023
Report Format: PDF

Download Free Sample

Breast Biopsy Devices Market Trends

Continuous advancements in biopsy technologies and equipment, such as more precise and minimally invasive techniques, improved imaging capabilities, and enhanced tissue sampling methods. For instance, Mammotome's Mammotome Elite Tetherless Biopsy System uses dual vacuum-assisted technology for precise breast biopsies and features an ergonomic design with multiple buttons for flexibility, enhancing efficiency in complex procedures.

Furthermore, public awareness campaigns and initiatives aimed at educating individuals about the importance of regular breast cancer screening and early detection have increased the demand for breast biopsy devices.
Therefore, this heightened awareness encourages more people to undergo screening, leading to higher utilization of biopsy devices, which is estimated to reach USD 4.8 billion by 2032.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global breast biopsy devices market was valued at USD 1.8 billion in 2022 and is estimated to reach USD 3.6 billion by 2032, backed by surge in breast cancer cases, favorable reimbursement policies, awareness about benefits of early detection.

The hospitals segment generated USD 1.1 billion in 2022 and will continue to drive demand as these healthcare settings leverage advanced infrastructure and skilled professionals to integrate sophisticated biopsy procedures seamlessly, gaining patient

U.S. market accounted for USD 649 million in 2022 and is predicted to witness substantial growth through 2032, primarily due to the advanced healthcare infrastructure, widespread access to cutting-edge diagnostic technologies, and proactive breast cancer awareness programs.

Stryker Corporation, Boston Scientific Corporation, FUJIFILM Holdings Corporation, Argon Medical Devices, Inc, Hologic Inc, Cook Group Incorporated, Becton, Dickinson and Company (BD), Medtronic plc, Olympus Corporation, Cardinal Health, and INRAD Inc among others.